C O M M U N I C A T I O N S
be detected.22 Optimization of the blocker and benzophenone
moieties may allow improved selectivity for the closed state; the
modular design of the molecule is expected to enable facile
synthesis of second-generation probes.
The potential utility of a channel-targeted ABPP strategy depends
on whether it will be generalizable to a large number of structurally
distinct channels. Large changes in pore structure (as judged by
accessibility to reactive probes in solution) have been observed for
other Cys-Loop receptors such as the serotonin receptor,23 as well
as glutamate receptors24 and potassium channels.25 In addition, the
many characterized state-selective channel blockers and inhibitors
offer a rich set of potential pore-binding groups for ion channel
targeted ABPP probes. Ion channels as a class thus share many of
the advantages of enzyme active sites as ABPP targets and appear
likely to be a generally useful target for ABPP techniques.
Acknowledgment. This work was supported by the Beckman
Foundation and the MIT Department of Chemistry.
Figure 2. Photolabeling nAChRs expressed in live cells in the absence
(closed) or presence (desensitized) of acetylcholine (ACh) demonstrates
that BPyneTEA preferentially binds closed receptors. Closed receptors are
labeled ∼2-fold more efficiently than desensitized receptors at concentrations
of 250 µM and 50 µM. At 10 µM BPyneTEA, differential labeling was not
statistically significant.
Supporting Information Available: Synthetic, electrophysiology,
and biochemical methods; discussion of blockade models and voltage-
dependence of blockade; statistical analysis of live-cell labeling; labeling
results in the absence of light or BPyneTEA. This material is available
states is not statistically significant (unpaired, two-sided t test, p )
0.068). The kinetic studies also allow estimation of upper limits
for dissociation constants of BPyneTEA binding to closed and open
states: <∼20 µM for the closed state and <∼80 µM for the open
state (Supporting Figure 3B).
References
(1) Jessani, N.; Cravatt, B. F. Curr. Opin. Chem. Biol. 2004, 8, 54–59.
(2) Liu, Y. S.; Patricelli, M. P.; Cravatt, B. F. Proc. Natl. Acad. Sci. U.S.A.
1999, 96, 14694–14699.
To test whether BPyneTEA selectively labels the closed (but
activatable) state of the nAChR compared to the inactive desensi-
tized state, we carried out photolabeling of nAChRs expressed in
live HEK293 cells in the presence or absence of the desensitizing
agonist acetylcholine. Closed or desensitized nAChRs were pho-
tolabeled with BPyneTEA, and copper(I)-catalyzed [3 + 2]
cycloaddition (i.e., “click” chemistry, as adapted for bioconjuga-
tion18) of an azide-functionalized biotin was carried out to bioti-
nylate the photolabeled receptors.19 Biotinylated receptors were
captured on streptavidin-coated beads, and nAChRs were visualized
by Western blotting with an antibody against the nAChR R subunit.
Quantification of the captured nAChRs (normalized for expression
levels) shows that, at BPyneTEA concentrations g50 µM, the closed
state is labeled more efficiently than the desensitized state by a
factor of ∼2 (Figure 2 and Supporting Table 1). At 10 µM
BPyneTEA, weak labeling is observed, but its state selectivity is
not statistically significant. Labeling was not observed in the absence
of BPyneTEA or UV irradiation (Supporting Figure 1).
Selectivity for closed states compared to desensitized states is
likely to be a crucial parameter in determining the utility of probes
for investigation of nAChR desensitization in ViVo. Because
desensitization occurs primarily from the open state and is the
thermodynamic minimum for the agonist-bound channel,20 only
channel populations that spend most of their time in the closed
state will remain activatable. The selectivity of BPyneTEA for
closed over desensitized conformations is modest (∼2-fold) but high
enough that comparison of subproteomes using mass spectrometry
is expected to be feasible. The use of trypsin-catalyzed 18O labeling
of peptides for relative quantification of subproteomes by mass
spectrometry21 has allowed enrichments/depletions of <2-fold to
(3) Yee, M.; Fas, S. C.; Stohlmeyer, M. M.; Wandless, T. J.; Cimprich, K. A.
J. Biol. Chem. 2005, 280, 29053–29059.
(4) Salisbury, C. M.; Cravatt, B. F. Proc. Natl. Acad. Sci. U.S.A. 2007, 104,
1171–1176.
(5) Kandel, E. R.; Schwartz, J. H.; Jessell, T. M. Principles of Neural Science,
4th ed.; McGraw-Hill Health Professions Division: New York, 2000.
(6) Quick, M. W.; Lester, R. A. J. J. Neurobiol. 2002, 53, 457–478.
(7) Wilson, G. G.; Karlin, A. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1241–
1248.
(8) Sine, S. M.; Quiram, P.; Papanikolaou, F.; Kreienkamp, H. J.; Taylor, P.
J. Biol. Chem. 1994, 269, 8808–8816.
(9) Heidmann, T.; Bernhardt, J.; Neumann, E.; Changeux, J. P. Biochemistry
1983, 22, 5452–5459.
(10) Mansvelder, H. D.; Keath, J. R.; McGehee, D. S. Neuron 2002, 33, 905–
919.
(11) Giniatullin, R.; Nistri, A.; Yakel, J. L. Trends Neurosci. 2005, 28, 371–
378.
(12) Elenes, S.; Ni, Y.; Cymes, G. D.; Grosman, C. J. Gen. Physiol. 2006, 128,
615–27.
(13) Akk, G.; Steinbach, J. H. J. Physiol. 2003, 551, 155–168.
(14) Garcia, G.; Chiara, D. C.; Nirthanan, S.; Hamouda, A. K.; Stewart, D. S.;
Cohen, J. B. Biochemistry 2007, 46, 10296–10307.
(15) Neher, E.; Steinbach, J. H. J. Physiol. 1978, 277, 153–176.
(16) Sine, S. M.; Ohno, K.; Bouzat, C.; Auerbach, A.; Milone, M.; Pruitt, J. N.;
Engel, A. G. Neuron 1995, 15, 229–239.
(17) Colquhoun, D.; Hawkes, A. G. In Single-Channel Recording; Sakmann,
B., Neher, E., Eds.; Plenum Press: New York, 1995; pp 397-482.
(18) Wang, Q.; Chan, T. R.; Hilgraf, R.; Fokin, V. V.; Sharpless, K. B.; Finn,
M. G. J. Am. Chem. Soc. 2003, 125, 3192–3193.
(19) Speers, A. E.; Adam, G. C.; Cravatt, B. F. J. Am. Chem. Soc. 2003, 125,
4686–4687.
(20) Auerbach, A.; Akk, G. J. Gen. Physiol. 1998, 112, 181–197.
(21) Yao, X.; Freas, A.; Ramirez, J.; Demirev, P. A.; Fenselau, C. Anal. Chem.
2001, 73, 2836–2842.
(22) Ramos-Fernandez, A.; Lopez-Ferrer, D.; Vazquez, J. Mol. Cell. Proteomics
2007, 6, 1274–1286.
(23) Panicker, S.; Cruz, H.; Arrabit, C.; Slesinger, P. A. J. Neurosci. 2002, 22,
1629–1639.
(24) Sobolevsky, A. I.; Beck, C.; Wollmuth, L. P. Neuron 2002, 33, 75–85.
(25) Liu, Y.; Jurman, M. E.; Yellen, G. Neuron 1996, 16, 859–867.
JA805868X
9
J. AM. CHEM. SOC. VOL. 130, NO. 47, 2008 15767